HEALTH CARE MANAGEMENT CLASS of 2020 PERMANENT PLACEMENT LIST Company Group Location (City, State) MEDICAL RESIDENCY E

Total Page:16

File Type:pdf, Size:1020Kb

HEALTH CARE MANAGEMENT CLASS of 2020 PERMANENT PLACEMENT LIST Company Group Location (City, State) MEDICAL RESIDENCY E HEALTH CARE MANAGEMENT CLASS OF 2020 Company PERMANENT PLACEMENT LIST Group Location (City, State) FINANCIAL SERVICES/VENTURE CAPITAL/P.E. Jordan Brown 1315 Capital Private Equity Philadelphia, PA Chris Greeno Asahi Kasei Corporate Venture Capital Boston, MA Jan Gong Baker Brothers Investments Investment Team New York, NY Garrett Klein Blackstone Private Equity New York Sam Kahn Blackstone Private Equity New York Danny McDonough Citadel - Surveyor Capital Healthcare New York Matt Baker Cortec Group Private Equity New York, NY Niyoshi Patel Dementia Discovery Fund / SV Health Biotech Venture Capital Boston, MA Romana Sohail Evercore NY M&A New York, NY David Wang HIG Capital Private Equity San Francisco, CA Sarah Weber Nantahala Capital Management Biotech public equities New York, NY Will Choi New Mountain Capital Private Equity New York Will Burton Shore Capital CXO - Portfolio Operations @ BrightView HealthCincinnati, OH F. Beau Brace SNH Capital Partners Private Equity Austin, TX Joe Blundo TCV HCIT, Education, HR Tech New York, NY Shilpa Topudurti The Cranemere Group Healthcare New York, NY Evan Cairo Triple Aim Partners Private Equity Chicago, IL HEALTH CARE MANAGEMENT CONSULTING M. Rita Costiv Accenture Strategy Digital Health Consulting New York, NY Ying Ying Shi Accenture Strategy Strategy Munich, Germany Andrew Bravo Bain & Company New York, NY Annie Fox Manatt Phelps & Phillips, LLC Manatt Health New York, NY Charles Gage Boston Consulting Group Atlanta, GA Will Davenport Boston Consulting Group Healthcare Miami Zach Laskin Boston Consulting Group New York, NY/Summit, NJ Jenn Thornton Boston Consulting Group N/A Boston, MA Jenny Fernandez Deloitte Consulting Public Sector - Healthcare Washington, DC Reena Kersch Deloitte Consulting Strategy Washington, DC Evan Strother McKinsey Digital / Healthcare San Francisco Schuyler Yost McKinsey Consulting New York, NY Andrew Lay Oliver Wyman Health and Life Sciences San Francisco/Los Angeles, CA Tommy Marder Putnam Associates Consulting New York HEALTH CARE PROVIDERS/HOSPITALS/PHYSICIAN GROUP PRACTICE Arpan Parikh, MD CareMore Health Behavioral Health Los Angeles, CA Diane Mosquera, MD Penn Medicine Department of Anesthesiology Philadelphia, PA Sheyda Bautista-Saeyan DaVita Redwoods Los Angeles, CA Parh Patel, DMD SC Management Dental Support Organization Philadelphia, PA Jenna Ackerman VillageMD Strategy Chicago, IL Aaron Thomas CarePoint Health System Chief of Staff Hoboken, NJ MANAGED CARE/INSURANCE Katherine Dunnigan Humana Leadership Rotational Program Rotates (Louisville, Boston, D.C.) Scott Heyman Humana Digital Health and Analytics Boston, MA Shuaiqing Liu Humana Leadership Rotation Program San Francisco, CA Dan Astrachan Humana Digital Health and Analytics Boston, MA Lora Rosenblum Cedar Business Development New York, NY Nina Underman Humana Strategic Operations, EDGE Health Boston, MA HEALTH CARE MANAGEMENT CLASS OF 2020 PERMANENT PLACEMENT LIST Company Group Location (City, State) MEDICAL RESIDENCY E. Ducky Duckworth Dell Medical School-Universty of Texas at Austin Orthopaedic Surgery Residency Austin, TX Olivia Jew Duke University Medical Center Dermatology Residency Durham, NC Ilana Nelson-Greenberg Johns Hopkins Bayview Hospital Primary Care/Internal Medicine Residency Baltimore, MD J. Andres Hernandez Reconstructive Plastic Surgery Residency Duke University Hospital Durham, NC Amanda Chin UCLA Health Vascular Surgery (Integrated) Residency Los Angeles, CA Harrison Lee UCSF Radiology Residency San Francisco, CA Prateek Agarwal University of Pittsburgh Medical Center Neurosurgery Residency Pittsburgh, PA Alomi Parikh University of Southern California Department of OphthalmologyResidency Los Angeles, CA PHARMACEUTICAL/BIOTECHNOLOGY/MED DEVICES/DIAG. Alexandra Hariri Celularity Business Development Warren, NJ Richard Woo Gilead Sciences Corporate Development Foster City, CA Shane Bouchard Magenta Therapeutics Commercial and Business Development Cambridge, MA Daichen Wei Merck Marketing Philadelphia, PA Kathryn Kelley Merck GMAP (Leadership Rotation Program) Philadelphia, PA or Kenilworth, NJ Hannah Bogardus Pfizer Marketing New York, NY Kristen Nehls Regeneron Pharmaceuticals Undecided Tarrytown, NY Natalie Pancer Turtle Health Head of Operations Boston, MA Elizabeth Morse Alynlam Business Development Cambridge, MA DIGITAL HEALTH/PROPULATION HEALTH MANAGEMENT/ANALYTICS Sophie Alpert Komodo Health Product New York, NY Elisabeth Berger Health at Scale Growth San Francisco, CA Misha Nasrollahzadeh Ribbon Health Business Development New York, NY Yiqin Jiang SOMOS Network Performance New York, NY Elston He Synovium (autoimmune disease-focused real world data / analytics)N/A Ann Arbor, MI Rishi Taggarsi Teladoc Leadership Development Program New York Scott Lever Teladoc Leadership Development Program New York UNDECIDED Jason Peterson Undecided Mike Greenberg Undecided Morgan Matthews Undecided.
Recommended publications
  • Billing Code: 6750-01S
    This document is scheduled to be published in the Federal Register on 11/28/2016 and available online at https://federalregister.gov/d/2016-28472, and on FDsys.gov BILLING CODE: 6750-01S FEDERAL TRADE COMMISSION Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules Section 7A of the Clayton Act, 15 U.S.C. 18a, as added by Title II of the Hart-Scott- Rodino Antitrust Improvements Act of 1976, requires persons contemplating certain mergers or acquisitions to give the Federal Trade Commission and the Assistant Attorney General advance notice and to wait designated periods before consummation of such plans. Section 7A(b)(2) of the Act permits the agencies, in individual cases, to terminate this waiting period prior to its expiration and requires that notice of this action be published in the Federal Register. The following transactions were granted early termination -- on the dates indicated -- of the waiting period provided by law and the premerger notification rules. The listing for each transaction includes the transaction number and the parties to the transaction. The grants were made by the Federal Trade Commission and the Assistant Attorney General for the Antitrust Division of the Department of Justice. Neither agency intends to take any action with respect to these proposed acquisitions during the applicable waiting period. Early Terminations Granted October 1, 2016 thru October 31, 2016 10/03/2016 20161722 G Hainan Cihang Charitable Foundation ; Blackstone Capital Partners (Cayman II) VI L.P. ; Hainan Cihang Charitable Foundation 20161727 G Wellforce Inc. ; Hallmark Health Corporation ; Wellforce Inc.
    [Show full text]
  • Investor Profile Report GEORGE R
    Investor Profile Report PRESENTED BY GEORGE R. BROWN CONVENTION CENTER March 9-10, 2016 Glossary Business Description: All investments by industry: A description of the firm’s primary type, Graph of transactions by industry, represented in preferences and location. PitchBook is an the PitchBook Platform. This breakdown is based impartial information provider on primary industries of the portfolio/serviced and will remove promotional language. companies. Assets under management (AUM): Specific to Lender Profiles The amount of money that the investor manages Total debt financings: for clients based on number of currently-managed The number of entities identified by PitchBook that funds. received debt financing from the firm in the last five years. Active private equity investments: The number of active companies in the investor’s Target debt financing amount: current portfolio identified by PitchBook in the Preferred amount of debt typically provided by last five years. This includes add-on transactions. the firm in a transaction. Total private equity investments: Specific to Service Provider Profiles The total number of companies in the investor’s Total transactions: portfolio, identified by PitchBook in the last five The number of transactions identified by years. This includes add-on transactions. PitchBook that the firm has provided service on in the last five years. Target EBITDA: Preferred EDITDA range targeted for investment. Total companies serviced: The number of unique companies the firm has Target revenue: provided service to in the last five years, identified Preferred revenue range targeted for investment. by PitchBook. Preferred investment amount: Total investors serviced: Preferred investment amount range that the firm The number of unique investors identified by typically invests in PitchBook that the firm has provided service to in a transaction.
    [Show full text]
  • Laser Scanners Vs Imagers How to Improve
    LASER SCANNERS VS IMAGERS Pg 2 - RASPBERRY PI pg 4 IS BARCODE FRIENDLY! HOW TO IMPROVE BARCODE READING SPEED pg 6 Pg 3 - RFID INDUSTRY A NEW ERA FOR LABELING CONVERGES IN PHOENIX pg 8 FOR TOP EVENT MORE INDUSTRY NEWS pg 10-40 2019 Q2 | https://barcode.com Raspberry Pi is Barcode Friendly; and Over 25 Million Units Sold RFID Industry Converges In By Craig Aberle, owner and publisher If you haven’t purchased and played with a Raspberry Pi com- Connecting bar code scanners to Phoenix For Top Event puter, you owe it to yourself to invest $75 or so and see what Raspberry Pi it can do. RFID Live was held in Phoenix Arizona this year, April Best Manufacturing RFID Implementation BAE Systems— The circuit board has 4 USB connections and I had no trou- 2nd-4th, and it was a great place to see the latest in RFID for its use of RFID to track tools, saving 1,248 hours that ble connecting some scanners I had laying around. One, a The tiny (about the size of a deck of playing cards) all-in-one technology. The event was kicked off with a keynote by workers previously spent annually searching for missing items Honeywell Voyager (mfg 10/2010) and the second, a Symbol computer is a powerhouse of performance. I have been RFID Journal Founder/Editor Mark Roberti, and followed and performing work-in-process, resulting in a reduction of LS2208 (mfg 10/2009), worked fine. No software updates or working with the latest version, Raspberry Pi 3 Model B+ and by a panel discussion on the implementation experiences of approximately 2,400 hours per year of time tracking WIP.
    [Show full text]
  • Executive Branch Personnel Public Financial Disclosure Report (OGE Form 278E)
    Nominee Report | U.S. Office of Government Ethics; 5 C.F.R. part 2634 | Form Approved: OMB No. (3209-0001) (March 2014) Executive Branch Personnel Public Financial Disclosure Report (OGE Form 278e) Filer's Information DeVos, Elisabeth P ("Betsy") Secretary, Department of Education Other Federal Government Positions Held During the Preceding 12 Months: Names of Congressional Committees Considering Nomination: ● Committee on Health, Education, Labor, and Pensions Electronic Signature - I certify that the statements I have made in this form are true, complete and correct to the best of my knowledge. /s/ DeVos, Elisabeth P ("Betsy") [electronically signed on 01/19/2017 by DeVos, Elisabeth P ("Betsy") in Integrity.gov] Agency Ethics Official's Opinion - On the basis of information contained in this report, I conclude that the filer is in compliance with applicable laws and regulations (subject to any comments below). /s/ Goodridge-Keiller, Marcella, Certifying Official [electronically signed on 01/19/2017 by Goodridge-Keiller, Marcella in Integrity.gov] Other review conducted by /s/ Sprague, Marcia, Ethics Official [electronically signed on 01/19/2017 by Sprague, Marcia in Integrity.gov] U.S. Office of Government Ethics Certification /s/ Shaub, Walter M, Certifying Official [electronically signed on 01/19/2017 by Shaub, Walter M in Integrity.gov] 1. Filer's Positions Held Outside United States Government # ORGANIZATION NAME CITY, STATE ORGANIZATION POSITION HELD FROM TO TYPE 1 The Stow Company - Holland, Inc. See Endnote Holland, Corporation Chief Creative 5/2016 11/2016 Michigan Officer 2 The Stow Company - Holland, Inc. See Endnote Holland, Corporation Director 6/1994 11/2016 Michigan 3 RCB Main Floor, LLC (d/b/a "Reserve GR, See Endnote Grand Rapids, Corporation Director 3/2010 11/2016 LLC") Michigan 4 The Stow Company See Endnote Holland, Corporation Director 5/2010 11/2016 Michigan 5 Neurocore, LLC See Endnote Grand Rapids, Corporation Member/Manag 2/2009 11/2016 Michigan er 6 Windquest Group, Inc.
    [Show full text]
  • Private Equity Benchmark Report
    Preqin Private Equity Benchmarks: All Private Equity Benchmark Report As of 31st March 2014 alternative assets. intelligent data. Preqin Private Equity Benchmarks: All Private Equity Benchmark Report As of 31st March 2014 Report Produced on 9th October 2014 This publication is not included in the CLA Licence so you must not copy any portion of it without the permission of the publisher. All rights reserved. The entire contents of the report are the Copyright of Preqin Ltd. No part of this publication or any information contained in it may be copied, transmitted by any electronic means, or stored in any electronic or other data storage medium, or printed or published in any document, report or publication, without the express prior written approval of Preqin Ltd. The information presented in the report is for information purposes only and does not constitute and should not be construed as a solicitation or other offer, or recommendation to acquire or dispose of any investment or to engage in any other transaction, or as advice of any nature whatsoever. If the reader seeks advice rather than information then he should seek an independent fi nancial advisor and hereby agrees that he will not hold Preqin Ltd. responsible in law or equity for any decisions of whatever nature the reader makes or refrains from making following its use of the report. While reasonable efforts have been used to obtain information from sources that are believed to be accurate, and to confi rm the accuracy of such information wherever possible, Preqin Ltd. Does not make any representation or warranty that the information or opinions contained in the report are accurate, reliable, up-to-date or complete.
    [Show full text]
  • YETI Holdings, Inc. (Exact Name of Registrant As Specified in Its Charter)
    Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the Securities and Exchange Commission on February 18, 2020 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 YETI Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 45-5297111 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 7601 Southwest Parkway Austin, Texas 78735 (512) 394-9384 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Matthew J. Reintjes President and Chief Executive Officer, Director YETI Holdings, Inc. 7601 Southwest Parkway Austin, Texas 78735 (512) 394-9384 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Bryan C. Barksdale John-Paul Motley, Esq. Senior Vice President, General Counsel and Secretary Robert Plesnarski, Esq. YETI Holdings, Inc. O'Melveny & Myers LLP 7601 Southwest Parkway 400 South Hope Street Austin, Texas 78735 Los Angeles, CA 90071 Approximate date of commencement of proposed sale to public: From time to time after the effective date of this registration statement. If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. o If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box.
    [Show full text]
  • Final Rule: Exemptions for Advisers to Venture Capital Funds, Private
    39646 Federal Register / Vol. 76, No. 129 / Wednesday, July 6, 2011 / Rules and Regulations SECURITIES AND EXCHANGE 6. No Redemption Rights The primary purpose of Congress in COMMISSION 7. Represents Itself as Pursuing a Venture repealing section 203(b)(3) was to Capital Strategy require advisers to ‘‘private funds’’ to 17 CFR Part 275 8. Is a Private Fund register under the Advisers Act.6 Private 9. Application to Non-U.S. Advisers [Release No. IA–3222; File No. S7–37–10] 10. Grandfathering Provision funds include hedge funds, private B. Exemption for Investment Advisers equity funds and other types of pooled RIN 3235–AK81 Solely to Private Funds With Less Than investment vehicles that are excluded $150 Million in Assets Under from the definition of ‘‘investment Exemptions for Advisers to Venture Management company’’ under the Investment Capital Funds, Private Fund Advisers 1. Advises Solely Private Funds Company Act of 1940 7 (‘‘Investment With Less Than $150 Million in Assets 2. Private Fund Assets Company Act’’) by reason of section Under Management, and Foreign 3. Assets Managed in the United States 3(c)(1) or 3(c)(7) of such Act.8 Section Private Advisers 4. United States Person 3(c)(1) is available to a fund that does C. Foreign Private Advisers AGENCY: Securities and Exchange 1. Clients not publicly offer the securities it 9 Commission. 2. Private Fund Investor issues and has 100 or fewer beneficial 10 ACTION: Final rule. 3. In the United States owners of its outstanding securities. A 4. Place of Business fund relying on section 3(c)(7) cannot SUMMARY: The Securities and Exchange 5.
    [Show full text]
  • Mezzanine & Private Equity Investment Quarterly News
    3Q 2008 HIMCO Mezzanine and Private Equity Investment Quarterly News Page 1 of 1 Please add [email protected] to your safe senders list to ensure that our messages reach you. View this email as a web page. 3rd Quarter 2008 Mezzanine & Private Equity Investment Quarterly News Hartford Investment Management Company's Mezzanine & Private Equity Group announces the recent completion of a mezzanine and private equity transaction and the realization of one investment: The Mezzanine and Private Equity Group announces that it has realized on its investment of $10.0 million in senior subordinated debt in The Cortland Companies, Inc. (Cortland) when the company was sold. Cortland is a global designer, manufacturer and distributor of custom-engineered electro-mechanical cables and umbilicals, high performance synthetic ropes and value-added steel cable and Realization on $10.0 assemblies. Cortland's products are utilized in critical applications in diverse end million in senior markets including offshore oil and gas, marine geophysical survey, commercial diving, subordinated debt marine transport, medical, security, defense and aerospace. This investment was made in 2007 to support the acquisition of Cortland by Cortec Group Fund III, L.P. The Mezzanine and Private Equity Group announces that it has invested $5.0 million in senior subordinated debt to support the growth of Papa Gino's Holding Corp. (PGH) by Bunker Hill Capital, L.P. PGH owns two dominant New England quick-service restaurant concepts: Papa Gino's, operating in the pizza/Italian segment, and D'Angelo Sandwich Shops, operating in the sandwich segment. Both concepts, each with over 35 years of operating history, hold significant market positions in their respective segments with a total of 373 company-owned, franchised and licensed restaurants located throughout New England.
    [Show full text]
  • Private Equity and Venture Capital
    Private Equity and Venture Capital At Williams Mullen, we define our private equity and venture capital practice broadly to address all the different types of transactions in which equity is sold in transactions by an issuer not involving any public offering. While Williams Mullen has a flourishing securities and corporate practice serving our clients who report publicly, we also know that the vast majority of capital raised in the United States is raised through exempt offerings and have focused for decades on serving this space. We are proud of our status as an acknowledged national leader in representing clients seeking and providing the types of funding that accompany transactions by an issuer not involving any public offering. By definition, our practice covers those transactions normally defined as being in the “private equity” and “venture capital” space. Our lawyers routinely help private equity and venture capital sponsors form their funds, conduct their own private placements, and then invest that capital in portfolio company acquisitions and minority investments. We help our investor clients and clients seeking investments to formulate innovative strategies for structuring financings, acquisitions of private and public companies (including unsolicited acquisitions), going private transactions, stock for stock acquisitions, spin-offs, split-offs, split-ups, acquisitions of minority interests as well as traditional private placements of equity, debt, and convertible securities. Once financed, our firm provides ongoing counsel to our private equity clients including general legal counseling, corporate governance matters, add-on acquisitions, and divestitures. We also help early-stage, mid-stage and later-stage companies as they prepare to find capital to finance their needs and, when they are ready to do so, assist them in capital financing transactions.
    [Show full text]
  • Calstrs Private Equity Portfolio Performance
    California State Teachers' Retirement System Private Equity Portfolio Performance As of September 30, 2020 CalSTRS Since Capital Capital Capital Inception Description VY Committed Contributed Distributed IRR* ACON Equity Partners 3.5, L.P. 2012 70,000,000 66,554,508 22,297,157 3.95 ACON Equity Partners IV, LP 2016 50,000,000 34,796,408 2,903,730 2.05 Acon-Bastion Partners II, L.P. 2006 40,000,000 37,183,693 63,682,857 12.20 Advent Central & Eastern Europe IV LP 2008 99,378,679 78,087,390 48,559,263 (9.64) Advent Global Technology L.P. 2020 100,000,000 36,999,998 - (5.89) Advent International GPE IX, L.P. 2019 300,000,000 105,750,002 - 37.34 Advent International GPE VI LP 2008 271,014,851 271,014,851 509,613,730 15.61 Advent International GPE VIII-D L.P. 2016 150,000,000 142,349,999 - 19.01 Advent LatAm PE Fund VII SCSP 2020 150,000,000 - - 0.00 Affinity Asia Pacific Fund III, L.P. 2007 150,000,000 143,609,847 199,879,655 9.14 Affinity Asia Pacific Fund V (NO.2) L.P. 2018 200,000,000 41,463,270 357,594 (3.25) AG Capital Recovery Partners VI, L.P. 2008 100,000,000 100,000,000 142,315,064 7.42 AG Capital Recovery Partners VII, L.P. 2010 164,208,774 164,208,982 201,626,611 5.11 Alchemy Plan (Estrellita) L.P. 2002 259,509,125 259,515,793 303,967,690 3.56 Alchemy Special Opportunities Fund III 2014 54,833,427 48,134,080 5,715,068 2.45 Alchemy Special Opportunities Fund IV L.P.
    [Show full text]
  • 2012 Corporate and Securities Deal Diary
    2012 Corporate and Securities Deal Diary www.BlankRome.com (Note: the economic terms of certain deals are not disclosed due to confi dentiality obligations) Mergers and Acquisitions Capital agreed to invest in Alencon Acquisition subject to Alencon Acquisition meeting certain milestones. Accutome, Inc., a supplier of ophthalmic medications, sup- plies, surgical instruments and diagnostic equipment, in its Derivix Corp., a financial services software company that acquisition by a U.S. subsidiary of Halma p.l.c. provides options analytics, risk visualization, and multi- broker electronic execution solutions to the industry’s lead- American Standard Energy Corp., an oil and natural gas ing options traders, sales traders, and hedge funds, in its production company, in the purchase of leasehold working sale to Flex Trade Systems, Inc. interests in approximately 72,300 net acres across Texas, North Dakota, Wyoming and Nebraska. General Cable Corporation (NYSE: BGC), a global leader in the development, design, manufacture, marketing Apotex, Inc., the largest Canadian-owned pharmaceuti- and distribution of copper, aluminum and fiber optic wire cal company, in its acquisition of all of the stock of Aveva and cable products, in connection with its acquisition of the Drug Delivery Systems, a global developer and manu- North American portion of Alcan Cable, the wire and cable facturer of transdermal patches for branded and generic business of Rio Tinto plc (Rio Tinto) (LSE: RIO), a 100-year- pharmaceuticals. old leader in the production of aluminum cable for the util- ity and building industries. The transaction was valued at Article 9 Agents LLC, a legal document provider, in its sale approximately $151 million.
    [Show full text]
  • Publishing, LLC See Endnote N/A $1,001 - $15,000 None (Or Less Than $201)
    Annual Report 2018 | U.S. Office of Government Ethics; 5 C.F.R. part 2634 | Form Approved: OMB No. (3209-0001) (January 2018) Executive Branch Personnel Public Financial Disclosure Report (OGE Form 278e) Filer's Information DEVOS, ELISABETH P SECRETARY, Department of Education Report Year: 2018 Other Federal Government Positions Held During the Preceding 12 Months: None Electronic Signature - I certify that the statements I have made in this form are true, complete and correct to the best of my knowledge. /s/ DEVOS, ELISABETH P [electronically signed on 05/14/2018 by DEVOS, ELISABETH P in Integrity.gov] Agency Ethics Official's Opinion - On the basis of information contained in this report, I conclude that the filer is in compliance with applicable laws and regulations (subject to any comments below). /s/ Goodridge-Keiller, Marcella, Certifying Official [electronically signed on 09/19/2018 by Goodridge-Keiller, Marcella in Integrity.gov] Other review conducted by /s/ Sprague, Marcia, Ethics Official [electronically signed on 09/18/2018 by Sprague, Marcia in Integrity.gov] U.S. Office of Government Ethics Certification DEVOS, ELISABETH P - Page 1 /s/ Christopher, Dale, Certifying Official [electronically signed on 12/03/2018 by Christopher, Dale in Integrity.gov] Data Revised 09/04/2018 Data Revised 08/29/2018 Data Revised 08/27/2018 Data Revised 08/23/2018 Data Revised 08/13/2018 Data Revised 08/07/2018 Data Revised 08/06/2018 Data Revised 08/02/2018 Data Revised 07/31/2018 Data Revised 07/30/2018 Data Revised 07/10/2018 Data Revised 07/02/2018 DEVOS, ELISABETH P - Page 2 1.
    [Show full text]